Verana Health Introduces AI Agent Claire for MIPS Data Submissions

April 28, 2026
Verana Health has launched Agent Claire, an AI tool that helps clinicians streamline data submissions for the Merit-based Incentive Payment System (MIPS). The agent is available through the American Academy of Ophthalmology’s IRIS Registry Quality Measures Dashboard.

Verana Health has released Agent Claire, an artificial intelligence agent designed to assist clinicians with data reporting for the Merit-based Incentive Payment System (MIPS), announced in a press release. The tool aims to simplify the submission process, reduce compliance risks, and improve reporting efficiency.

Agent Claire is integrated into the Quality Measures Dashboard used by qualifying members of the American Academy of Ophthalmology's IRIS Registry. The system unifies clinical data to help users meet MIPS requirements and maintain accuracy while keeping pace with frequent regulatory updates.

According to Verana Health, the AI agent draws on the company’s experience in MIPS compliance support to guide medical practices in submitting accurate data and monitoring performance thresholds. The company plans to expand the agent’s capabilities across its suite of software applications for life sciences organizations.

Verana Health will host a webinar titled “From Rescue to Resilience: Boost Efficiency and Compliance in MIPS Submissions” on May 14 to provide further details about Agent Claire and its use in clinical workflows.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

04/28
Onymos and Mayo Clinic Partner on Intelligent Document Processing for Healthcare
04/28
IMO Health Opens Direct Access to Clinical Knowledge Graph for AI Developers
04/28
Permanente Leaders Recognized for AI and Value Based Care Advances
04/28
Fathom Therapeutics Raises $47 Million to Advance AI Drug Design Platform
04/28
SquareMind Raises $18 Million for AI and Robotics Skin Exam Platform

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like